Upstream Bio (UPB) Current Leases (2023 - 2026)
Upstream Bio's (UPB) quarterly Current Leases came in at $724000.0 in Q1 2026, up 2.26% year-on-year from $708000.0 in Q1 2025, and up 0.56% quarter-over-quarter from $720000.0 in Q4 2025.
Upstream Bio (UPB) Current Leases (2023 - 2026) Analysis & Trends
Upstream Bio's Current Leases history runs 4 years deep, the most recent figure standing at $724000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 2.26% year-over-year to $724000.0 in Q1 2026; TTM through Mar 2026 was $724000.0, a 2.26% increase from a year earlier, with the FY2025 full-year figure at $720000.0, up 2.27% from the prior year.
- Current Leases advanced to $724000.0 in Q1 2026 per UPB's latest filing, from $720000.0 in the prior quarter.
- Across five years, Current Leases topped out at $724000.0 in Q1 2026 and bottomed at $45000.0 in Q4 2023.
- The 4-year median for Current Leases is $710000.0 (2025), against an average of $625875.0.
- Across the five-year window, Current Leases soared 1464.44% in 2024 and gained 2.26% in 2026, its largest moves.
- Year by year, Current Leases stood at $45000.0 in 2023, then surged by 1464.44% to $704000.0 in 2024, then grew by 2.27% to $720000.0 in 2025, then increased by 0.56% to $724000.0 in 2026.
- Per Business Quant, the three latest UPB Current Leases figures stand at $724000.0 (Q1 2026), $720000.0 (Q4 2025), and $716000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Upstream Bio | 347.73 Mn | 347.73 Mn | -3.94 Mn | 724,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,000.00 |
| Dec 31, 2025 | 720,000.00 |
| Sep 30, 2025 | 716,000.00 |
| Jun 30, 2025 | 712,000.00 |
| Mar 31, 2025 | 708,000.00 |
| Dec 31, 2024 | 704,000.00 |
| Sep 30, 2024 | 678,000.00 |
| Dec 31, 2023 | 45,000.00 |